Sanofi
Zaltrap ‘no’ from NICE
June 21, 2013Sales and Marketing NICE, Sanofi, Zaltrap
NICE is preparing to discard Sanofi’s Zaltrap as an NHS option for treating metastatic colorectal cancer (mCRC) that is resistant …
Sanofi makes Curie cancer deal
June 20, 2013Research and Development, Sales and Marketing Cancer, R&D, Sanofi, curie
Sanofi has signed a three-year research collaboration with the Curie Institute to identify new therapeutic targets which will help develop …
Sanofi admits $285m failure
June 4, 2013Research and Development, Sales and Marketing Sanofi, its benzamide iniparib, otamixaban
Sanofi has consigned two investigational drugs to the corporate dustbin, preferring a $285 million dent in its coffers to continuing …
Positive news for Sanofi asthma drug
May 23, 2013Sales and Marketing Dupilumab, Regeneron, Sanofi, asthma
An asthma drug being developed by Sanofi and Regeneron Pharmaceuticals has performed well in a Phase IIa trial, reducing the …
Sanofi’s performance dives
May 3, 2013Sales and Marketing Q1, Sanofi
Sanofi suffered a grim first three months of 2013, with sales dipping and profit plummeting as loss of exclusivity took …
Sanofi appoints two executive members
May 3, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Sanofi, executive
Sanofi has announced a new commercial organisation which results in the appointment of two executives. Following the retirement of Hanspeter …
Sanofi reinforces presence in Morocco
April 19, 2013Manufacturing and Production Morocco, Sanofi, emerging markets, logistics
Sanofi has opened a new logistics hub in Morocco to help it increase and accelerate distribution of its medicines throughout …
Sanofi earmarks $75m for Vietnamese plant
April 19, 2013Manufacturing and Production Sanofi, vietnam
Sanofi has broken ground on a new manufacturing facility in Ho Chi Minh City, Vietnam, as part of its push …
Zaltrap launched in UK
March 4, 2013Sales and Marketing Sanofi, Zaltrap
Sanofi and Regeneron Pharmaceuticals’ bowel cancer drug Zaltrap has been launched in the UK today. Zaltrap (aflibercept) will be used …
Genzyme’s Waterford plant gets new investment round
February 19, 2013Manufacturing and Production Genzyme, Sanofi, Waterford
Sanofi’s Genzyme unit plans to spend €44 million on upgrading its plant in Waterford, Ireland, to help meet demand for …
Nanobiotix appoints ex-Sanofi head Alain Herrera
February 14, 2013Manufacturing and Production, Research and Development, Sales and Marketing Sanofi, nanobiotix
Nanomedicine firm Nanobiotix has announced that Dr Alain Herrera joins its Supervisory Board, succeeding Thierry Chopin and Isabelle Bou Antoun …
Sanofi ups stake in Regeneron
February 13, 2013Sales and Marketing AMD, Regeneron, Sanofi, Zaltrap
Sanofi is increasing its stake in Regeneron Pharmaceuticals by buying shares on the open market and from existing shareholders. The …
Sanofi won’t follow trend for spin-offs
February 8, 2013Sales and Marketing Abbott, Pfizer, Sanofi, Viehbacher
Sanofi’s chief executive Chris Viehbacher says the firm plans to maintain its portfolio of business divisions for the foreseeable future, …
Sanofi celebrates EU approvals
February 5, 2013Sales and Marketing Lyxumia, Sanofi, Zaltrap, diabetes
Sanofi is celebrating after diabetes treatment Lyxumia (lixisenatide) and metastatic colorectal cancer (mCRC) drug Zaltrap received authorisation in Europe. The …
Sanofi global operations president to retire
December 20, 2012Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Hanspeter Spek, Sanofi
Sanofi has announced that Hanspeter Spek, president, Global Operations, will retire from his current role in mid-2013. Christopher Viehbacher, chief executive …
Latest content
Five Facts about cardiovascular disease
